Clinical Trials on Specific Language Disorder

Total 144476 results

University of Alabama, Tuscaloosa
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Not yet recruiting

Recognition of Second Language Spoken Words, Signs, and Characters Via Perception and Production in Adults

Second Language Acquisition in Healthy Young Adults

United States
Weill Medical College of Cornell University

Completed

Intervention for Anxiety After Falls

Anxiety | Specific Phobia | Posttraumatic Stress Disorder (PTSD)

United States
University Hospital, Montpellier
Hôpital Necker-Enfants Malades

Completed

Language Environment in Children With Cochlear Implants (ISLODA)

Language Development
University Hospital, Angers

Unknown

Establishing the Language Network With Independent Component Analysis of Resting State MRI (ICA Langage)

Languages

France
Aveiro University

Completed

Table to Tablet (T2T): A Novel Intervention Framework for Children With Speech Sound Disorders

Speech Disorders

Portugal
Jean-Marie Annoni

Completed

Impact of Theta Burst Stimulation Over the Left DLPFC on Language Switching

Languages

Switzerland
Erasmus Medical Center

Terminated

Web-based Attention Bias Modification Treatment for Childhood Anxiety Disorders (ATTENTIO)

Generalized Anxiety Disorder | Social Anxiety Disorder | Specific Phobia | Anxiety Disorder | Anxiety Disorder of Childhood | Separation Anxiety Disorder of Childhood, Early Onset

Netherlands
Ulrik Lassen

Recruiting

Copenhagen Prospective Personalized Oncology (CoPPO) (CoPPO)

Unspecified Adult Solid Tumor, Protocol Specific

Denmark
University Health Network, Toronto
National Cancer Institute (NCI)

Completed

Kidney and Blood Pressure Changes in Patients Receiving Bevacizumab, Aflibercept, Sunitinib, or Cediranib for Cancer (NCI 8076)

Unspecified Adult Solid Tumor, Protocol Specific

Canada
Case Comprehensive Cancer Center

Completed

FLT-PET/MRI for Early Response Monitoring to Novel Cancer Therapeutic Agents

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Wisconsin, Madison
National Cancer Institute (NCI)

Completed

Perifosine in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Abramson Cancer Center of the University of Pennsylvania
National Cancer Institute (NCI)

Completed

Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Montefiore Medical Center
National Cancer Institute (NCI)

Completed

Ixabepilone and Ketoconazole in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
The University of Texas Health Science Center,...

Completed

Ultrasound Confirmation of Endotracheal Tube Location Using a Saline Filled Cuff (ET_Tube)

Pediatric Endotracheal Intubation (no Specific Condition)

United States
Genzyme, a Sanofi Company

Completed

SR-45023A in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Chicago
National Cancer Institute (NCI)

Terminated

Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies

Unspecified Adult Solid Tumor, Protocol Specific

United States
Georgetown University
National Cancer Institute (NCI)

Completed

Telephone-Based Cancer Education With or Without Telephone-Based Counseling in Young Participants

Unspecified Childhood Solid Tumor, Protocol Specific

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Completed

Extracranial Stereotactic Radiosurgery in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
R-Pharm
National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center

Completed

BMS-247550 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)

Completed

Paclitaxel in Treating Older Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

High-Selenium Brassica Juncea, Irinotecan, and Capecitabine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
University of Surrey

Completed

Selenium in the Prevention of Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United Kingdom
National Cancer Institute (NCI)

Completed

Smokefree.Gov Website in Helping United States Federal Employees Quit Smoking

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

UCN-01, Fluorouracil, and Leucovorin in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients Who Have Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Interleukin-2 Plus Activated White Blood Cells in Treating Patients With Cancer That Has Not Responded to Chemotherapy or Radiation Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

KRN5500 in Treating Patients With Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Bryostatin 1 Plus Gemcitabine in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Terminated

Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Palliative Care Intervention in Patients With Solid Tumors Participating in Phase I Clinical Trials

Unspecified Adult Solid Tumor, Protocol Specific

United States
SRI International
National Cancer Institute (NCI)

Completed

Varenicline Tartrate With Telephone-Based Counseling and/or Internet-Based Counseling in Helping Adults Stop Smoking

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Josephine Ford Cancer Center
National Cancer Institute (NCI)

Unknown

Internet-Based Nutrition Education Program in Preventing Cancer in Participants of Health Maintenance Organizations

Unspecified Adult Solid Tumor, Protocol Specific

United States
Montclair State University
National Cancer Institute (NCI)

Unknown

Promoting Physical Activity In After-School Programs for Urban Adolescents

Unspecified Adult Solid Tumor, Protocol Specific

United States
Brown University
National Cancer Institute (NCI)

Unknown

Personalized Nutrition Education in Improving Eating Habits of Healthy Participants Who Eat an Unhealthy Diet

Unspecified Adult Solid Tumor, Protocol Specific

United States
Dartmouth-Hitchcock Medical Center
National Cancer Institute (NCI)

Completed

Health Education in Improving the Understanding of Medical Information

Unspecified Adult Solid Tumor, Protocol Specific
Children's Cancer and Leukaemia Group

Unknown

Pharmacokinetics of Dactinomycin in Young Patients With Cancer

Unspecified Childhood Solid Tumor, Protocol Specific

Ireland, United Kingdom
Vion Pharmaceuticals

Completed

Combination Chemotherapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Lombardi Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
Vion Pharmaceuticals

Completed

VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy

Unspecified Adult Solid Tumor, Protocol Specific

United States
Brown University
National Cancer Institute (NCI)

Completed

Nutrition Education for Low-Income Healthy Participants Who Eat an Unhealthy Diet

Unspecified Adult Solid Tumor, Protocol Specific

United States
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Jonsson Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Vaccine Therapy in Treating Patients With Advanced Cancer

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Paclitaxel Plus Topotecan in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

3-AP and Doxorubicin In Treating Patients With Metastatic or Refractory Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Completed

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
Roswell Park Cancer Institute

Completed

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States

Clinical Trials on Specific Language Disorder

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Azerbaijan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations